Tuttle KR , et al.. Diabetic kidney disease: A report from an ADA Consensus Conference. Diabetes Care 2014; 37:2864–2883.

• PubMed
Tuttle KR , . Diabetic kidney disease: A report from an ADA Consensus Conference. Diabetes Care 2014; 37:2864–2883.)| false
• Search Google Scholar
• Export Citation

Molitch ME , et al.. Diabetic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes. Kidney Int 2015; 87:20–30.

• PubMed
Molitch ME , . Diabetic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes. Kidney Int 2015; 87:20–30.)| false
• Search Google Scholar
• Export Citation

Inzucchi SE , et al.. Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015; 38:140–149.

• PubMed
Inzucchi SE , . Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015; 38:140–149.)| false
• Search Google Scholar
• Export Citation

Davies MJ , et al.. Management of hyperglycemia in type 2 diabetes, 2018: A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018; 41:2669–2701.

• PubMed
Davies MJ , . Management of hyperglycemia in type 2 diabetes, 2018: A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018; 41:2669–2701.)| false
• Search Google Scholar
• Export Citation

American Diabetes Association. Pharmacologic approaches to glycemic treatment. Section 9. In Standards of Medical Care in Diabetes–2019. Diabetes Care 2019; 42[Suppl 1]:S90–S102.

• PubMed
American Diabetes Association. Pharmacologic approaches to glycemic treatment. Section 9. In Standards of Medical Care in Diabetes–2019. Diabetes Care 2019; 42[Suppl 1]:S90–S102.)| false
• Search Google Scholar
• Export Citation

Garber AJ , et al.. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm: 2019 executive summary. Endocrine Pract 2019; 25:69–101.

• PubMed
Garber AJ , . Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm: 2019 executive summary. Endocrine Pract 2019; 25:69–101.)| false
• Search Google Scholar
• Export Citation

Das SR , et al.. 2018 ACC Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: A report of the American College of Cardiology task force on expert consensus decision pathways. J Am Coll Cardiol 2018; 72:3200–3223.

• PubMed
Das SR , . 2018 ACC Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: A report of the American College of Cardiology task force on expert consensus decision pathways. J Am Coll Cardiol 2018; 72:3200–3223.)| false
• Search Google Scholar
• Export Citation

Lipscombe L , et al.. Diabetes Canada Clinical Practice Guidelines Expert Committee. 2018 Clinical Practice Guidelines. Pharmacologic glycemic management of type 2 diabetes in adults. Can J Diabetes 2018; 42[Suppl 1]:S88–S103.

• PubMed
Lipscombe L , . Diabetes Canada Clinical Practice Guidelines Expert Committee. 2018 Clinical Practice Guidelines. Pharmacologic glycemic management of type 2 diabetes in adults. Can J Diabetes 2018; 42[Suppl 1]:S88–S103.)| false
• Search Google Scholar
• Export Citation

Stone JA , et al.. Diabetes Canada Clinical Practice Guidelines Expert Committee. 2018 Clinical Practice Guidelines. Cardiovascular protection in people with diabetes. Can J Diabetes 2018; 42(Suppl 1):S162–S169.

• PubMed
Stone JA , . Diabetes Canada Clinical Practice Guidelines Expert Committee. 2018 Clinical Practice Guidelines. Cardiovascular protection in people with diabetes. Can J Diabetes 2018; 42(Suppl 1):S162–S169.)| false
• Search Google Scholar
• Export Citation

McFarlane P , et al.. Diabetes Canada Clinical Practice Guidelines Expert Committee. Chronic kidney disease in diabetes. Can J Diabetes 2018; 42[Suppl 1]:S201–S209.

• PubMed
McFarlane P , . Diabetes Canada Clinical Practice Guidelines Expert Committee. Chronic kidney disease in diabetes. Can J Diabetes 2018; 42[Suppl 1]:S201–S209.)| false
• Search Google Scholar
• Export Citation

Chiang C-E , et al.. 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of the Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular disease. J Chinese Med Assoc 2018; 81:189–222.

• PubMed
Chiang C-E , . 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of the Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular disease. J Chinese Med Assoc 2018; 81:189–222.)| false
• Search Google Scholar
• Export Citation

LeRoith D , et al.. Treatment of diabetes in older adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2019; 104:1520–1574.

• PubMed
LeRoith D , . Treatment of diabetes in older adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2019; 104:1520–1574.)| false
• Search Google Scholar
• Export Citation

Jia W , et al.. on behalf of the Chinese Diabetes Society. Standards of medical care for type 2 diabetes. Diabetes Metab Res Rev 2019; Mar 25:e3158. doi: 10.1002/dmrr.3158.

• PubMed
Jia W , . on behalf of the Chinese Diabetes Society. Standards of medical care for type 2 diabetes. Diabetes Metab Res Rev 2019; Mar 25:e3158. doi: 10.1002/dmrr.3158.)| false
• Search Google Scholar
• Export Citation